https://www.marketscreener.com/quote/stock/INOVIO-PHARMACEUTICALS-IN-17937428/news/INOVIO-Completes-Enrollment-of-Phase-1B-Clinical-Trial-for-its-DNA-Vaccine-Candidate-Against-Lassa-F-36783132/?utm_source=telegram&utm_medium=social&utm_campaign=share